Suppr超能文献

2004年博茨瓦纳在产前护理中引入常规艾滋病毒检测

Introduction of routine HIV testing in prenatal care--Botswana, 2004.

出版信息

MMWR Morb Mortal Wkly Rep. 2004 Nov 26;53(46):1083-6.

Abstract

In 2003, approximately 37% of pregnant women in Botswana (2001 population: 1.7 million; approximately 40,000 births per year) were infected with human immunodeficiency virus (HIV). Since 2001, all prenatal clinics in Botswana have offered HIV screening and interventions for prevention of mother-to-child transmission of HIV (PMTCT), which can decrease vertical transmission of HIV from 35%-40% to 5%-10%. Historically, HIV testing in Botswana has been performed after individual pretest counseling, with patients actively choosing whether to be tested (i.e., an "opt-in" approach). In 2003, 52% of pregnant women receiving prenatal care nationwide learned their HIV status. In 2004, to increase use of free national PMTCT and antiretroviral treatment (ARV) programs, Botswana began routine, noncompulsory (i.e., "opt-out") HIV screening in prenatal and other health-care settings. Concerns have been raised that routine testing in Africa might deter women from seeking prenatal care and might result in fewer women returning for their test results and HIV care after testing. To assess the early impact of routine testing on HIV-test acceptance and rates of return for care, the CDC Global AIDS Program and the PMTCT program in Botswana evaluated routine prenatal HIV testing at four clinics in Francistown, the second largest city in Botswana, where HIV prevalence has been > or =40% since 1995. This report describes the results of that assessment, which indicated that, during February-April 2004, the first 3 months of routine testing, 314 (90.5%) of 347 pregnant women were tested for HIV, compared with 381 (75.3%) of 506 women during October 2003-January 2004, the last 4 months of the opt-in testing period (p<0.001). However, many women who were tested never learned their HIV status because of logistical problems or not returning to the clinic. Substantial increases in HIV testing of pregnant women were also observed at the Francistown referral hospital and at prenatal clinics nationwide. These findings highlight the potential public health impact of routine HIV testing with rapid, same-day results for programs seeking to increase the number of persons with access to HIV-prevention and treatment services.

摘要

2003年,博茨瓦纳约37%的孕妇(2001年人口:170万;每年约40000例分娩)感染了人类免疫缺陷病毒(HIV)。自2001年以来,博茨瓦纳所有的产前诊所都提供HIV筛查及预防母婴传播HIV(PMTCT)的干预措施,这可将HIV的垂直传播率从35% - 40%降至5% - 10%。从历史上看,博茨瓦纳的HIV检测是在进行个体检测前咨询后进行的,患者主动选择是否接受检测(即“选择加入”方式)。2003年,全国接受产前护理的孕妇中有52%了解了自己的HIV感染状况。2004年,为了增加免费的国家PMTCT和抗逆转录病毒治疗(ARV)项目的使用,博茨瓦纳开始在产前及其他医疗保健机构进行常规的、非强制性的(即“选择退出”)HIV筛查。有人担心在非洲进行常规检测可能会使女性不愿寻求产前护理,并且可能导致接受检测的女性中较少有人回来获取检测结果及HIV护理。为评估常规检测对HIV检测接受度及护理回访率的早期影响,美国疾病控制与预防中心全球艾滋病项目以及博茨瓦纳的PMTCT项目在博茨瓦纳第二大城市弗朗西斯敦的四家诊所评估了常规产前HIV检测情况,自1995年以来该地区的HIV流行率一直≥40%。本报告描述了该评估结果,结果表明,在2004年2月至4月,即常规检测的前3个月,347名孕妇中有314名(90.5%)接受了HIV检测,而在2003年10月至2004年1月,即“选择加入”检测期的最后4个月,5个6名孕妇中有381名(75.3%)接受了检测(p<0.001)。然而,由于后勤问题或未返回诊所,许多接受检测的女性从未得知自己的HIV感染状况。在弗朗西斯敦转诊医院及全国的产前诊所也观察到孕妇HIV检测率大幅上升。这些发现凸显了对于旨在增加获得HIV预防和治疗服务人数的项目而言常规HIV检测及快速当日出结果的潜在公共卫生影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验